271 related articles for article (PubMed ID: 12208453)
1. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
2. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.
Shono Y; Nishihara H; Matsuda Y; Furukawa S; Okada N; Fujita T; Yamamoto A
J Pharm Sci; 2004 Apr; 93(4):877-85. PubMed ID: 14999725
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.
Nerurkar MM; Ho NF; Burton PS; Vidmar TJ; Borchardt RT
J Pharm Sci; 1997 Jul; 86(7):813-21. PubMed ID: 9232522
[TBL] [Abstract][Full Text] [Related]
4. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
Hugger ED; Novak BL; Burton PS; Audus KL; Borchardt RT
J Pharm Sci; 2002 Sep; 91(9):1991-2002. PubMed ID: 12210046
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.
Collnot EM; Baldes C; Wempe MF; Kappl R; Hüttermann J; Hyatt JA; Edgar KJ; Schaefer UF; Lehr CM
Mol Pharm; 2007; 4(3):465-74. PubMed ID: 17367162
[TBL] [Abstract][Full Text] [Related]
6. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R
Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127
[TBL] [Abstract][Full Text] [Related]
7. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
8. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure.
Al-Ali AAA; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2018 Nov; 551(1-2):270-280. PubMed ID: 30240828
[TBL] [Abstract][Full Text] [Related]
9. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
10. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
14. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.
Collnot EM; Baldes C; Wempe MF; Hyatt J; Navarro L; Edgar KJ; Schaefer UF; Lehr CM
J Control Release; 2006 Mar; 111(1-2):35-40. PubMed ID: 16410030
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
16. Digestion of surfactants does not affect their ability to inhibit P-gp-mediated transport in vitro.
Rasmussen AJ; Pedersen M; Griffin BT; Holm R; Nielsen CU
Int J Pharm; 2024 May; 656():124120. PubMed ID: 38621613
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.
Wempe MF; Wright C; Little JL; Lightner JW; Large SE; Caflisch GB; Buchanan CM; Rice PJ; Wacher VJ; Ruble KM; Edgar KJ
Int J Pharm; 2009 Mar; 370(1-2):93-102. PubMed ID: 19100824
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).
Dintaman JM; Silverman JA
Pharm Res; 1999 Oct; 16(10):1550-6. PubMed ID: 10554096
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants.
Jakobsen S; Gaenaelle Gé L; Pedersen M; Griffin BT; Holm R; Uhd Nielsen C
Int J Pharm; 2022 Aug; 624():121885. PubMed ID: 35690306
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity.
Dudeja PK; Anderson KM; Harris JS; Buckingham L; Coon JS
Arch Biochem Biophys; 1995 May; 319(1):309-15. PubMed ID: 7771801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
